Related Experiment Video

Updated: Jan 9, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

28.4K

Empirical Antifungal Therapy and IAPA in Influenza-Associated ARDS: Insights from Real-World Data

Stefan Hatzl1,2,3,4, Robert Krause4,5

  • 1Intensive Care Unit, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|December 4, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

11.0K
Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

10.6K

Related Experiment Videos

Last Updated: Jan 9, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

28.4K
Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

11.0K
Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

10.6K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

731
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
731
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

988
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
988

Articles linked to this work by shared authors, journal, and citation graph.

The role of 1-3-beta-D-glucan in predicting Pneumocystis jirovecii Pneumonia in Immunocompromised Children.

Journal of the Pediatric Infectious Diseases Society·2026

Population pharmacokinetics, target attainment and individualized dosing of isavuconazole in critically ill adults receiving extracorporeal membrane oxygenation.

JAC-antimicrobial resistance·2026

Erythrocyte and Platelet Indices at Admission and Discharge Stratify Long-Term Cardiovascular Risk After Invasive Treatment of Myocardial Infarction.

Journal of clinical medicine·2026

Triazoles Versus Echinocandins for the First-Line Treatment of Invasive Pulmonary Aspergillosis: A Propensity Score-Weighted Multicenter Study.

Open forum infectious diseases·2025

Applying DanGer Shock Eligibility Criteria to a Real-World Cohort of Cardiogenic Shock Patients.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2025

Empirical Antifungal Treatment of Critically Ⅲ Patients With Influenza-Associated Acute Respiratory Distress Syndrome: A Propensity Score Weighted Observational Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

Characterizing measles healthcare facility exposures-December 2023-September 2025-New York City.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Antibodies targeting blood stage antigens of Plasmodium falciparum are associated with resistance to malaria infection and disease.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

A Multistate Investigation of Serious Adverse Events, including Deaths, following Ceftriaxone Injections, September 2024-August 2025.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

From bedside to broadband: Evaluating outcomes of telehealth infectious diseases consultations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Cefepime versus piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Direct Initiation of Long-Acting Cabotegravir Plus Rilpivirine in People with HIV and Suboptimal Virologic Suppression: A Randomized Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Pre-Pandemic Scientific Insights into Influenza A (H3N2): Viral Evolution, Host Responses, and Evidence-Based Preventive Strategies.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2026

Targeting of NLRP3 Gln624/Ser658 by Carabrone attenuates inflammatory diseases.

European journal of pharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us